![]()
|
|
||||||||
J. Biol. Chem., Vol. 266, Issue 15, 9580-9585, May, 1991
B Poulain, S Mochida, U Weller, B Hogy, E Habermann, JD Wadsworth, CC Shone, JO Dolly and L Tauc
The neuroparalytic activities of botulinum neurotoxin type A (BoNT A),
tetanus toxin (TeTx), or homologous and heterologous combinations of their
constituent polypeptides were examined at cholinergic and non- cholinergic
synapses of Aplysia californica. When applied extracellularly, BoNT A or a
mixture of its heavy (HC) and light (LC) chains were far more potent in
blocking transmitter release at cholinergic than non-cholinergic synapses.
The reverse was true for TeTx or a mixture its constituent chains. Such
selectivity was assigned to differences in neuronal targetting and uptake
of the neurotoxins since both exhibited similar potencies when injected
directly into the cell body of either cell type. When bath-applied,
heterologous combinations of the toxins' HC and LC appeared as effective as
the parent neurotoxins from whence each HC was derived. Moreover,
targetting/internalization was attributable to the analogous N-terminal
moieties, H2 and beta 2, of the HC from BoNT A and TeTx. Thus, it may be
postulated that the latter regions possess two functional domains, one
being distinct and responsible for the divergent neuronal specificity,
whereas the other serves a common role in translocating the LC of either
toxin. Also, it was shown that the C-terminal portion of the HC of TeTx is
unable to play the intracellular role of its counterpart in BoNT A.
Heterologous combinations of heavy and light chains from botulinum neurotoxin A and tetanus toxin inhibit neurotransmitter release in Aplysia
Laboratoire de Neurobiologie Cellulaire et Moleculaire, Centre National de la Recherche Scientifique, Gif-sur-Yvette, France.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
G. Schiavo, M. Matteoli, and C. Montecucco Neurotoxins Affecting Neuroexocytosis Physiol Rev, April 1, 2000; 80(2): 717 - 766. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Byrne, T. J. Smith, V. A. Montgomery, and L. A. Smith Purification, Potency, and Efficacy of the Botulinum Neurotoxin Type A Binding Domain from Pichia pastoris as a Recombinant Vaccine Candidate Infect. Immun., October 1, 1998; 66(10): 4817 - 4822. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Coffield, N. Bakry, R.-d. Zhang, J. Carlson, L. G. Gomella, and L. L. Simpson In Vitro Characterization of Botulinum Toxin Types A, C and D Action on Human Tissues: Combined Electrophysiologic, Pharmacologic and Molecular Biologic Approaches J. Pharmacol. Exp. Ther., March 1, 1997; 280(3): 1489 - 1498. [Abstract] [Full Text] |
||||
![]() |
M. A. Bittner, M. K. Bennett, and R. W. Holz Evidence That Syntaxin 1A Is Involved in Storage in the Secretory Pathway J. Biol. Chem., May 10, 1996; 271(19): 11214 - 11221. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Cornille, F. Deloye, M.-C. Fournié-Zaluski, B. P. Roques, and B. Poulain Inhibition of Neurotransmitter Release by Synthetic Proline-rich Peptides Shows That the N-terminal Domain of Vesicle-associated Membrane Protein/Synaptobrevin Is Critical for Neuro-exocytosis J. Biol. Chem., July 14, 1995; 270(28): 16826 - 16832. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |